Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy

Clinical trial NCT03776643 · COMPLETED

Trial details

NCT number: NCT03776643
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis to Birch Pollen With a Positive Skin Prick Test to Birch Pollen

Start date: 2019-02-01
Primary completion: 2022-08-16
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.